Clayton, Dubilier & Rice, LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 29, 2026), Clayton, Dubilier & Rice, LLC reported 2 stock positions worth $895.0 million. Its top holding was Resideo Technologies (REZI) at 52.1% of the portfolio, followed by Agilon Health (AGL, 47.9%). Compared with Q1 2026, it added to 1. The biggest buy was Resideo Technologies (REZI, shares +0%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001538642
- Portfolio Value
- $895.0M (Q2 2026)
- SEC Filing
- 0001104659-26-087892 ↗ filed Jul 29, 2026
Holdings Value
Holdings 2 stocks · $895.0M
Portfolio Sells Q1 2026 → Q2 2026
| None this quarter. | |||
Portfolio Buys Q1 2026 → Q2 2026
| REZI Resideo Technologies Inc. | Add +0.1% | 52.10% | −42.01 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 2 | $895.0M | REZI, AGL |
| Q1 2026 | 2 | $536.5M | REZI, AGL |
| Q4 2025 | 2 | $595.0M | REZI, AGL |
| Q3 2025 | 2 | $676.7M | REZI, AGL |
| Q2 2025 | 2 | $357.3M | AGL, REZI |
| Q1 2025 | 2 | $435.8M | AGL, BECN |
| Q4 2024 | 3 | $192.6M | AGL, BECN, FTDR |
| Q3 2024 | 4 | $401.6M | AGL, GPK, BECN, FTDR |
| Q2 2024 | 4 | $661.9M | AGL, GPK, BECN, FTDR |
| Q1 2024 | 4 | $618.7M | AGL, GPK, BECN, FTDR |